Sun Pharmaceutical Industries Ltd (SPIL) and its executives, including its MD Dilip Shanghvi, have settled a case with capital market regulator SEBI over alleged fund diversion by the company and its subsidiary Sun Pharmaceutical Laboratories .
The
Branded Generics Market research report thoroughly explains each and every aspect related to the Global Branded Generics Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business.
Branded Generics Market Insight:
Global Branded Generics Market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026. This rise in market value can be attributed to growing need for cheaper treatment options and pharmaceutical drugs required by patients.
Whistle blower complaints alleged that transactions with AML were ongoing for several years, but it was disclosed as a related party of SPIL only in FY 2017-18.The
Dietary Supplements Market Investigation Highlights Contribution by Leading Players, untill 2023 The Global Dietary Supplements Market 2020 report delivers a fundamental overview of the industry, including definitions, segmentation, applications and industry chain structure analysis.
BriefingWire.com, 2/10/2021 - The Global Dietary Supplements Market 2020 report delivers a fundamental overview of the industry, including definitions, segmentation, applications and industry chain structure analysis. The global dietary supplements market report provides competitive landscape analysis, major trends, and key regional development status. It also offers a competitive framework for major revenue-contributing firms covering company market shares with comprehensive profiles. The report provides a key overview of the market status of dietary supplements market manufacturers with market size, share, growth, market expansion, and technological